mirtazapine has been researched along with Chromosome-Defective Micronuclei in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sołek, P | 1 |
| Mytych, J | 1 |
| Tabęcka-Łonczyńska, A | 1 |
| Koziorowski, M | 1 |
| Norizadeh Tazehkand, M | 1 |
| Topaktas, M | 1 |
2 other studies available for mirtazapine and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxe | 2021 |
The in vitro genotoxic and cytotoxic effects of remeron on human peripheral blood lymphocytes.
Topics: Adrenergic alpha-Antagonists; Adult; Cell Proliferation; Cells, Cultured; Dose-Response Relationship | 2015 |